Similarly, in BC tissues the negative correlation was confirmed by IHC, highlighting a new androgen-induced AR activating signal pathway that directly upregulates let-7a and negatively regulates CMYC and KRAS, inhibiting proliferation of AR+/ER- cells (Lyu et al., 2014). Here, AR is linked to breast cancer.